from Actualités at http://bit.ly/2uREzpO on July 31, 2017 at 08:37PM La cohorte Constances est une « Infrastructure nationale en biologie et santé » labellisée par le Programme des Investissements d’avenir. Ouverte à la collectivité de recherche, elle apporte également des informations pour l’Assurance maladie, et permet le suivi de nombreux indicateurs de santé publique. 

Single-Payer is the American Way

from THCB at http://bit.ly/2vbaN28 on July 31, 2017 at 05:35PM By MARGALIT GUR-ARIE As is customary for every administration in recent history, the Trump administration chose to impale itself on the national spear known as health care in America. The consequences so far are precisely as I expected, but one intriguing phenomenon is surprisingly beginning […]

Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation study

from The European Journal of Health Economics at http://bit.ly/2vf6vGu on July 31, 2017 at 03:09PM Abstract Most health insurers in the Netherlands apply community-rating and open enrolment for supplementary health insurance, although it is offered at a free market. Theoretically, this should result in adverse selection. There are four indications that adverse selection indeed has […]

Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review

from PharmacoEconomics – Open at http://bit.ly/2vlAv4e on July 31, 2017 at 02:42PM Abstract Background Little evidence is available on the management and cost of treating patients with advanced or metastatic gastric cancer (GC). This study evaluates patient characteristics, treatment patterns, and resource utilization for these patients in Mexico. Methods Data were collected from three centers […]

Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis

from PharmacoEconomics at http://bit.ly/2vXJaak on July 31, 2017 at 12:36PM Abstract Background Genomic tests may improve the stratification of patients to receive new therapies in several disease areas. However, the use of expensive targeted therapies can impact on the cost effectiveness of these tests. This study presents an economic evaluation of genomic testing in chronic […]

BMJ Paper: Pharma Trial Transparency ‘Highly Variable’

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2vjqS6r on July 30, 2017 at 07:48PM According to a paper published July 26 in The BMJ, pharmaceutical companies have mostly inconsistent policies regarding trial transparency. The authors assessed the policies of 42 pharmaceutical companies. Policies across the 42 companies were described as “highly variable.” “Of 23 companies […]

FDA Slates First Meeting of Patient-Centered Committee

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2tOU8xo on July 30, 2017 at 07:18PM The Food and Drug Administration has scheduled the first meeting of the new Patient Engagement Advisory Committee (PEAC) for Oct. 11-12. The patient-centered board will help facilitate better communications between patients and physicians, manufactures, other patients and even the FDA. According […]

Time devoted by elderly people to physical activities: micro-econometric evidence from Spain

from Health Economics at http://bit.ly/2v8egOT on July 30, 2017 at 09:31AM In this paper, I analyse the differences in the time devoted to walking, cycling, gymnastics, and hunting by the elderly in Spain, considering own and socio-demographic characteristics. Using data from the Spanish Time-Use Survey (STUS) 2009-10, I estimate a simultaneous SUR model with data […]

Long-Run Changes in the Body Mass Index of Adults in Three Food-Abundant Settler Societies: Australia, Canada and New Zealand

from Health Economics at http://bit.ly/2uNlcy5 on July 30, 2017 at 09:31AM We identify changes in body mass index (BMI) since the 19th century, for three British-origin, food abundant, settler societies: Australia, Canada and New Zealand. The onset of sustained BMI increase came later in these societies than in the US. New Zealand shows a distinctive […]

Going after the Addiction, Not the Addicted: The Impact of Drug Decriminalization in Portugal

from Health Economics at http://bit.ly/2v8nPgF on July 30, 2017 at 09:31AM This paper investigates the impact of drug decriminalization in Portugal using the Synthetic Control Method. The applied econometric methodology compares Portuguese drug-related variables with the ones extracted from a convex combination of similar European countries. The results suggest that a policy change implemented in […]

The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan and South Korea

from Health Economics at http://bit.ly/2uNXbam on July 30, 2017 at 09:31AM We propose a novel framework to analyse the macroeconomic impact of non-communicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone gross domestic […]

The Impact of the Affordable Care Act’s Medicaid Expansion on Medicaid Spending by Health Care Service Category

from Health Economics at http://bit.ly/2v89oJF on July 30, 2017 at 09:31AM The 2014 Medicaid expansion revised Medicaid eligibility provisions to allow for low-income, non-elderly adults to be eligible for Medicaid in those states which opt for this change. During the first two years after the expansion, there were more than 10.7 million newly eligible Medicaid […]

Exploring health outcomes by stochastic multi-objective acceptability analysis: an application to Italian regions.

from Health Economics at http://bit.ly/2uNJE2o on July 30, 2017 at 09:31AM This paper introduces the Stochastic Multi-Objective Acceptability Analysis (SMAA) in order to investigate the evolution of mortality rates in the Italian regions over the period 1990-2013. We propose to explore the overall outcome of health care by a Composite Index (CI) of mortality based […]

Community Participation on Health Management: A Case of Dengue Fever Disease Control Program

from Health Economics at http://bit.ly/2v8dVfd on July 30, 2017 at 09:31AM Community Participation on Health Management: A Case of Dengue Fever Disease Control ProgramAnusorn Kunanusorn1 PhDChanita Chotisatiankul, ProfessorAbstract Dengue Fever disease has been one of public health problems in urban and rural areas of Thailand for many years. The Royal Thai Government has spent large […]